Binding Site Competitors and Similar CompaniesClear all

Binding Site's competitors and similar companies include EKF Diagnostics, SpeeDx, QIAGEN and Transine Therapeutics.
Binding Site
Binding Site
Binding Site is a company that provides specialist diagnostic products to clinicians and laboratory professionals.
EKF Diagnostics
EKF Diagnostics
EKF Diagnostics Holdings is a company that manufactures point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose, and lactate.
SpeeDx
SpeeDx
SpeeDx is a provider of multiplex quantitative polymerase chain reaction (qPCR) and isothermal amplification solutions for clinical diagnostics.
QIAGEN
QIAGEN
QIAGEN is a company that provides sample technology solutions.
Transine Therapeutics
Transine Therapeutics
Transine Therapeutics is a developer of biotech platform tat specializes in development of therapeutic RNAs.
Founding Date
Founding Date
1983
Founding Date
1990
Founding Date
2009
Founding Date
1984
Founding Date
2020
Type
Type
Private
Type
Public
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Birmingham, GB HQ
Locations
Penarth, GB HQ
Shanghai, CN
Barleben, DE
Leipzig, DE
Boerne, US
Elkhart, US
Locations
Eveleigh, AU HQ
London, GB
Austin, US
Locations
Venlo, NL HQ
Clayton, AU
São Paulo, BR
Toronto, CA
Beijing, CN
Guangzhou, CN
Shanghai, CN
see more
Locations
Babraham, GB HQ
Employees
Employees
6681% decrease
Employees
303
Employees
842% decrease
Employees
5,6541% decrease
Employees
517% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
157.5 m
Valuation ($)
N/A
Valuation ($)
9.3 b
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
£108.2m (FY, 2021)
Revenue (est.)
£51.6m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
$2.1b (FY, 2025)
Revenue (est.)
N/A
Cost of goods
Cost of goods
£32.9m (FY, 2021)
Cost of goods
£19.7m (FY, 2025)
Cost of goods
N/A
Cost of goods
$577.3m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
£75.3m (FY, 2021)
Gross profit
£32.1m (FY, 2025)
Gross profit
N/A
Gross profit
$1.5b (FY, 2025)
Gross profit
N/A
Net income
Net income
£25.3m (FY, 2021)
Net income
£2.5m (FY, 2025)
Net income
N/A
Net income
$437m (FY, 2025)
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 15m (over 6 years ago)
Latest funding round
N/A
Latest funding round
$ 12.6m (almost 5 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 30m
Total funding raised
$ 4m
Total funding raised
$ 12.6m
For sources of this data, please see the company profile

View Company Profiles

EKF Diagnostics
HQ
Penarth, GB
Employees
303

EKF Diagnostics Holdings is a company that manufactures point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose, and lactate.

View company
SpeeDx
HQ
Eveleigh, AU
Employees
84↓ 2% decrease

SpeeDx is a provider of multiplex quantitative polymerase chain reaction (qPCR) and isothermal amplification solutions for clinical diagnostics.

View company
QIAGEN
HQ
Venlo, NL
Employees
5,654↓ 1% decrease

QIAGEN is a company that provides sample technology solutions.

View company
Transine Therapeutics
HQ
Babraham, GB
Employees
5↓ 17% decrease

Transine Therapeutics is a developer of biotech platform tat specializes in development of therapeutic RNAs.

View company